ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $228,000 | -30.5% | 10,516 | -10.0% | 0.09% | -24.3% |
| Q2 2022 | $328,000 | -13.0% | 11,686 | +42.9% | 0.12% | -1.7% |
| Q1 2022 | $377,000 | -43.6% | 8,176 | +2.8% | 0.12% | -33.1% |
| Q4 2021 | $669,000 | +7.2% | 7,956 | -15.1% | 0.18% | +2.9% |
| Q3 2021 | $624,000 | +29.5% | 9,366 | +3.3% | 0.17% | +25.0% |
| Q2 2021 | $482,000 | -3.0% | 9,066 | -20.8% | 0.14% | -11.1% |
| Q1 2021 | $497,000 | +9.2% | 11,446 | +30.6% | 0.15% | +7.0% |
| Q4 2020 | $455,000 | +66.1% | 8,766 | +4.5% | 0.14% | +41.6% |
| Q3 2020 | $274,000 | +5.0% | 8,386 | +54.6% | 0.10% | -1.9% |
| Q2 2020 | $261,000 | – | 5,426 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |